Home Infusion Therapy Market By Product Type (Infusion Pumps { Elastomeric, Electromechanical, Gravity, Others}, Intravenous Sets, IV Cannulas, Needleless Connectors, Drugs), By Application (Anti-infective, Endocrinology, {Diabetes, and Others} Hydration Therapy, {Athletes, and Others} Chemotherapy, Enteral Nutrition, Parenteral Nutrition, Specialty Pharmaceuticals, Others), By Service Model (Home Health Agencies, Specialty Pharmacy Providers, Telehealth Services, Others), Global Market Size, Segmental analysis, Regional Overview, Company share analysis, Leading Company Profiles And Market Forecast, 2025 – 2035

Industry Outlook

The Home Infusion Therapy market accounted for USD 36.5 Billion in 2024 and is expected to reach USD 92.3 Billion by 2035, growing at a CAGR of around 8.8% between 2025 and 2035.  Infusion therapy refers to infusing a variety of ANS drugs into the patient via the vascular system through the catheter and is generally conducted in a convenient setting, which is the patient's own home. It improves patient comfort, healthcare cost reduction, and quality of life by keeping individuals as normal during treatment as possible.

The uptick in technology development, the elderly population, and the growing abundance of sentiments for chronic diseases offer momentum in the home infusion therapy market. The major players in this field are pharmaceutical companies, home healthcare providers, and technology companies that make infusion devices and software. Generally, home infusion therapy asserts a major shift toward patient-centered care in the medical field.

Report Scope:

Market Dynamics

• Increased demand for effective long-term home healthcare solutions.

The increased demand for effective long-term home healthcare solutions provides a significant driver for the home infusion therapy market. With the increase in the world population suffering from chronic diseases such as diabetes, heart disease, and cancer, continued rising demand is apparent for patients needing long-term treatment delivered predominantly at home. This is comforting and convenient while improving patient management of complicated therapies.

According to statistics from the Centers for Disease Control and Prevention, as many as 6 out of every 10 adults in the U.S. live with at least one chronic disease, showing a demand for readily accessible and efficient home care. Patient-centered care policies promoting home healthcare can also bring it out as an alternative approach to traditional hospital settings. As a result, this could continue to push the demand for home infusion therapy since the structure of healthcare systems is changing to better meet patient needs.

• Home infusion reduces hospitalization costs for patients and healthcare systems.

Home infusion therapy is one home infusion therapy of the most important drivers in the healthcare market due to saving significant hospitalization costs for patients and healthcare systems. It enables healthcare providers to minimize expensive hospital stays.

According to the Agency for Healthcare Research and Quality (AHRQ), such care reduced readmission rates from clinics or hospitals by as much as 25%, showing a great deal of achievement in this regard in patient outcome improvement and cost minimization. In this era of ever-increasing cost-container pressure within healthcare facilities, demand for home infusion therapy will expand and benefit patients and the healthcare infrastructure.

• Potential risks from unsupervised home treatment discourage patients.

The potential risk associated with unsupervised home treatment is a significant restraint for the home infusion therapy market. Patients may have fears of self-infusion of medications without professional supervision. The possible complications, such as infections or overdosing, may discourage them from opting for home therapy. 

Furthermore, access to immediate medical help in case of an emergency causes heightened anxiety. Factors can limit the growth of the home infusion market, as many patients prefer the safety and reassurance of receiving treatment in a clinical setting.

• Remote monitoring enhances patient management and support for home therapies.

Remote monitoring provides an excellent opportunity for the home infusion therapy market, supporting enhanced patient management and care. With the development of technology, healthcare providers can monitor patients' vital signs and infusion progress while in patients' homes continuously. With this, timely intervention in case of any problems arising has been enhanced, enabling the patients to receive care when they require it. Patients are then assured safety and greater confidence in the home management of their therapies.

The technology also allows for enhanced communication between the patient and care teams, allowing changes in treatment to be made according to real-time data. This results in an entirely new, confident, and empowered patient in their journey of home therapy, where more satisfaction and compliance with therapy are expected. Such an increase in confidence creates a growth opportunity in the home infusion market since more patients start to avail themselves of the comfort of receiving care in their own homes.

• Personalized treatments cater specifically to diverse patient needs and conditions.

Personalized treatment presents a significant opportunity to address the individualized needs of patients in the home infusion therapy market. Since every patient has distinct medical conditions, preferences, and treatment responses, customized therapy plans inevitably lead to better outcomes when rendered. By tailoring infusion therapies for specific patients, healthcare provides an opportunity for patients to receive medications and dosages effectively. Such personalization also enhances customer satisfaction and treatment adherence since the patients feel their special needs are being catered to. Moreover, with the rising demand for individualized healthcare, home infusion therapy can ride on this trend to attract more patients. The personalized approach will inevitably make the home infusion market grow in more patient-centered healthcare.

Industry Experts Opinion

“Patients can undergo an onboarding process via an app, followed by an evaluation by a nurse practitioner during an infusion visit. Within 48 hours, patients are connected with a Lyn Health care team to access virtual chronic care management care, including behavioral health services.”

• Jane Himmelvo, CEO of Lyn Health

Segment Analysis

Based on the product type, the market of Home Infusion Therapy has been classified into Infusion Pumps, Intravenous Sets, IV Cannulas, Needleless Connectors, and Drugs. In-home infusion therapy market, infusion pumps, especially electromechanical pumps, would hold a large share of it. Such devices are essential for chronic disease management because of their precise control of the drug delivery that ensures patient safety and treatment value. With the gradual acceptance of home healthcare, the demand for such pumps has increased. They provide further comfort in therapy to patients, thus reducing hospital visits. Moreover, the evolution of technology has given rise to portable and easy-to-operate models, making them suitable for home use.

Based on the Application type, the market of Home Infusion Therapy has been classified into Anti-infective, Endocrinology, Hydration Therapy, Chemotherapy, Enteral Nutrition, Parenteral Nutrition, Specialty Pharmaceuticals, and Others. In the home infusion therapy market, the anti-infective application is the most dominant segment. This covers the infusion of antibiotics and antivirals, mostly paramount for treating infections, particularly with patients with weakened immune systems or chronic illnesses. Rising incidence rates of infectious diseases, together with the increase in antibiotic-resistant strains, have escalated the demand for effective home-based treatments.

 Also, in-home infusion of anti-infectives allows comfort for patients while decreasing the duration of their hospital stays, which is in line with the growing trend of healthcare delivery at home. Other advances in infusion technology have enabled patients to self-manage their treatment at home, improving adherence and outcomes. This keeps other elements of this segment at the forefront of improving the quality of life for patients while addressing important healthcare needs.

Regional Analysis

The home infusion therapy market in North America is experiencing significant growth driven by the increased prevalence of chronic diseases and rising acceptance of care at home. In the United States, which has the most accommodating healthcare system and payment guidelines, this category has the best margin. Key players are focusing on new technology innovations and improving patient outcomes, which, in turn, spur the expansion of the market. Further to this is COVID-19's push towards more home-based care models, not only urging but pushing providers toward more flexible therapeutics. Patient awareness and acceptance of home infusion therapy will witness seasoned investments and the development of products and services.

The United States represents an incredibly large and relatively robust scope of the home infusion therapy market due to the increase in an older population, coupled with a plethora of chronic diseases, such as diabetes and heart diseases. Modern technologies such as smart infusion devices and telehealth solutions are stepping up to enhance patient management and monitoring for better outcomes. This, in addition to positive reimbursement schemes with supportive employees from clinical establishments, facilitates the market's growth.

The Asia Pacific home infusion therapy market is characterized by fast growth, which can be attributed to the aging population and the increase in patients suffering from chronic diseases. The leaders of the pack are Japan and China, which boast well-established healthcare systems and an ever-increasing demand for home-based care. Technological advancements seen in infusion devices and telehealth are enhancing safety and accessibility and making home therapies more attractive. Besides, patient-centered care and cost-effectiveness also promote adoption. Overall, this does create a rosy future on the one hand by emphasizing digital health solutions that promise better patient outcomes.

With an increased aging population and prevalence of chronic diseases, Japan is currently the leader in the home infusion market. In particular, the growing demand for home-based medical services can be attributed to an advanced healthcare system with safety and usability innovations in infusion devices that patients have been presented with. With the ever-growing awareness of home healthcare, more opportunities will open up to expand the market when combined with telehealth solutions and smart technologies. This will help Japan remain at the forefront in this sector.

Competitive Landscape

The home infusion therapy market is highly competitive. Major key players in this market are Baxter International, Fresenius Kabi, and B. Braun Melsungen. The focus areas for these companies remain centered upon innovations and product expansion due to the increasing demand from patients who wish to receive treatment at their homes. Baxter's new products and services include advanced infusion systems that are safer for the patient and more user-friendly, while Fresenius Kabi invested in digital health solutions to make infusion therapy management more efficient.

UnitedHealth Group's acquisition of Optum Home Infusion Services also indicates the trend towards integrated care models, establishing these companies for future growth in this very rapidly changing market. With healthcare increasingly moving into more personal, consumer-friendly interfaces, all of them compete with each other, and competition is expected to heighten further.

Home Infusion Therapy Market, Company Shares Analysis, 2024

To explore in-depth analysis in this report - Request Free Sample Report

Recent Developments:

• In April 2024, Baxter International Inc. announced that its Novum IQ large volume infusion pump (LVP), equipped with Dose IQ Safety Software, has obtained 510(k) approval from the U.S. Food and Drug Administration. This system enables clinicians to utilize a unified, integrated approach across various patient care environments. The introduction of the Novum IQ LVP in the U.S. highlights Baxter's dedication to continuous innovation in infusion therapy.
• In February 2024, Dynamic Access, LLC introduced Dynamic Infusion, a new affiliate brand dedicated to providing home infusion nursing services for patients with chronic conditions like autoimmune disorders, hemophilia, Crohn's disease, rheumatoid arthritis, and multiple sclerosis, among others. This initiative will enhance the operations of two established firms, each boasting over a decade of experience in delivering home infusion nursing services to patients across the Northeast.

Report Coverage:

By Product Type

•  Infusion Pumps
  • Elastomeric
  • Electromechanical
  • Gravity
  • Others
• Intravenous Sets
• IV Cannulas
• Needleless Connectors     
• Drugs    

By Application

• Anti-infective
• Endocrinology
  • Diabetes
  • Others
• Hydration Therapy
  • Athletes
  • Others
• Chemotherapy
• Enteral Nutrition
• Parenteral Nutrition
• Specialty Pharmaceuticals
• Others

By Service Model

• Home Health Agencies
• Specialty Pharmacy Providers
• Telehealth Services
• Others

By Region

North America

• U.S.
• Canada

Europe

• U.K.
• France
• Germany
• Italy
• Spain
• Rest of Europe

Asia Pacific

• China
• Japan
• India
• Australia
• South Korea
• Singapore
• Rest of Asia Pacific

Latin America

• Brazil
• Argentina
• Mexico
• Rest of Latin America

Middle East & Africa

• GCC Countries
• South Africa
• Rest of the Middle East & Africa

List of Companies:

• Baxter International Inc.
• B. Braun Melsungen AG
• Fresenius Kabi AG
• Medtronic plc
• Terumo Corporation
• Pfizer Inc.
• Amedisys Inc.
• Optum Home Infusion Services
• CVS Health Corporation
• Linde plc
• UnitedHealth Group Incorporated
• McKesson Corporation
• Novartis AG
• Graham-Field Health Products, Inc.
• Nipro Corporation
• Koru Medical Systems, Inc.
• Zynex Inc.
• Calea Limited

Frequently Asked Questions (FAQs)